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The manifestations of the HIV pandemic are manifold, 
affecting all organ systems. With respect to the vascular sys-
tem, it is recognised that vasculitides constitute one of the 
less common but none the less challenging consequences of 
HIV infection.1 The HIV pandemic has also seen a dramatic 
increase in the prevalence of Kaposi’s sarcoma2 and its fre-
quently associated complication of chronic lymphoedema.3 
When these three manifestations of HIV (Kaposi’s sarcoma, 
lymphoedema and vasculopathy) coexist in the same limb, 
as in this report, unique clinical and management challenges 
are presented.
Case report 
A 34-year-old man who had been confirmed HIV positive a 
year earlier presented to the surgical services at King Edward 
VIII Hospital, Durban, with a 1-month history of rest pain in 
the right leg with associated gangrene of the little toe. 
In addition to generalised lymphadenopathy, the patient 
was noted to have right femoro-popliteal arterial disease with 
dry gangrene of the right fifth toe and skin changes sugges-
tive of ischaemic changes along the second, third and fourth 
toes. Purple nodular lesions were noted on both lower limbs, 
suggestive of Kaposi’s sarcoma. Non-pitting oedema up to 
the level of the right knee was also evident, less so on the 
opposite limb. The clinical assessment was critical ischaemia 
of the right lower limb with associated chronic lymphoedema 
secondary to Kaposi’s sarcoma. 
The haemoglobin level was 12.6 g/dl, the white cell count 
8.2×109/l, and the platelet count 479×109/l. The urea and 
electrolyte levels and the results of liver function tests were 
normal. The international normalised ratio (INR) measured 
1.08 and the CD4 count was 110 cells/µl.
The thrombophilia screen (antithrombin III, protein C, 
protein S levels) was normal. A skin biopsy of the nodular 
lesions confirmed Kaposi’s sarcoma. The chest radiograph 
was normal. A venous Doppler study excluded a deep-vein 
thrombosis. 
The right common and superficial femoral arteries 
appeared normal on arterial duplex Doppler examination. 
However, extensive ‘beading’ was noted in the right popliteal 
artery, which appeared patent at the knee. A thrombus was 
noted in the distal popliteal artery with a ‘knocking’ pulse. 
No flow was detected in the distal popliteal or tibial arteries 
at the ankle. 
A computed tomography angiogram of the lower limbs 
revealed a sharp cut-off of vessels below the right knee, sug-
gestive of thrombus formation. Poor distal flow was noted, 
and the rest of the vessels were normal. 
The patient was commenced on highly active antiretroviral 
therapy (HAART) and anticoagulation. A distal limb abla-
tion was undertaken after demarcation of the gangrenous 
segments. The patient is currently receiving oncotherapy for 
management of the Kaposi’s sarcoma. 
Discussion 
Understanding the pathogenesis and formulating the effective 
management of HIV-associated vasculopathy and Kaposi’s 
sarcoma-associated lymphoedema remains a challenge to 
the attendant practitioner. When these manifestations of 
HIV occur together (and on the same limb) this challenge is 
increased, since the treatment of one may compromise the 
treatment of the other.
Kaposi’s sarcoma is caused by Kaposi’s sarcoma-associated 
herpesvirus (KSHV), also known as human herpesvirus 8 
(HHV8). In the early 1980s the increasingly frequent diagno-
sis of Kaposi’s sarcoma in AIDS patients led to the inference 
that AIDS weakened the immune system.4
The incidence of Kaposi’s sarcoma has declined sharply 
since HAART became widely available, and HAART is 
indispensable in the treatment of epidemic Kaposi’s sarcoma. 
In 40% or more of patients with AIDS-related Kaposi’s 
sarcoma, the lesions will regress upon commencement of 
HAART.5,6 In some patients, however, Kaposi’s sarcoma may 
recur after years of HAART, especially if HIV is not com-
Kaposi’s sarcoma, lymphoedema and 
gangrene in AIDS – a therapeutic 
challenge
S. EBRAHIM, M.B. CH.B. 
B. SINGH, F.C.S. (S.A.), M.D. 
J. MOODLEY, F.C.S. (S.A.), M.MED.SCI. 
Department of General Surgery, Nelson R. Mandela School of Medicine, Faculty of Health Sciences, University 
of KwaZulu-Natal, Durban
P. K. RAMDIAL, F.C.PATH. (S.A.), M.MED.
Department of Pathology, Nelson R. Mandela School of Medicine
Case Report
VOL 47, NO. 2, MAY 2009   SAJS
Kaposi.indd   62 5/25/09   3:57:03 PM
SAJSARTICLES
 63
pletely suppressed. Patients with a few local lesions can often 
be treated with local measures such as radiation therapy 
or cryotherapy. Surgery is generally not recommended, as 
Kaposi’s sarcoma can appear in wound edges. More wide-
spread disease, or disease affecting internal organs, is gener-
ally treated with systemic therapy with interferon alpha and 
liposomal anthracyclines.7
Obstructive lymphoedema caused by AIDS-related 
Kaposi’s sarcoma, although previously rare, is now being seen 
with increasing frequency.2 It is suggested that lymphatic 
and venous obstruction, protein-rich interstitial fluid, tissue 
haemosiderin and subcutaneous infection contribute to the 
evolution and perpetuation of chronic lymphoedema.3 
Morbidity and mortality in patients with Kaposi’s sarcoma-
associated lymphoedema is influenced by coexistent sepsis 
because of stasis and trauma; the recognition of infection 
may therefore be limb- or life-saving.2
Many types of vasculitis have been reported in HIV-posi-
tive patients, affecting mainly small and medium-sized ves-
sels. Large vessels can also be involved, usually as part of a 
leucocytoclastic vasculitis of the vasa vasora or periadventitial 
vessels.1 Large-vessel vasculopathy consists of either aneu-
rysms or occlusive disease. Arteries affected include the com-
mon carotid, abdominal aorta, common iliac, femoral and 
popliteal.7
Primary arterial thrombosis associated with HIV infection, 
as in the case reported here, is a distinct clinicopathologi-
cal entity. Young patients particularly are at increased risk. 
Involvement of both upper and lower limbs is documented, 
presenting with varying degrees of ischaemia ranging from 
claudication to frank tissue necrosis.8
Vascular occlusion is on the basis of an organising localised 
thrombus within the vessel lumen, with no evidence of ath-
erosclerosis in the intima. The major changes involve the 
adventitia and the peri-adventitial area, with leucoclastic 
vasculitis of the vasa vasora.8 Significant features include the 
normality of the arterial tree proximal to the thrombosed 
arteries, and thrombosis of the distal vessels with no demon-
strable run-off. Typically, Duplex ultrasonography shows 
hyperechoic ‘spotting’ in the arterial wall with the ‘string of 
pearls’ sign, found to be a sensitive indicator of HIV throm-
bosis.9
While several causes of primary HIV-associated thrombo-
sis have been documented, its pathophysiology is not well 
understood. In general, HIV infection is associated with 
aberrations of coagulation that include thrombocytopenia 
and hypercoagulable states. Hypercoagulable states are pre-
disposed to by acquired protein C and protein S deficiency, 
as well as by elevated levels of antiphospholipid antibodies 
and von Willebrand factor. 
Thrombectomy usually results in thrombus recurrence 
within 48 hours, and whether it impacts on level of ablation 
is not known at present. The anecdotal use of steroids after 
thrombectomy has not been found to prevent re-thrombosis. 
Vascular grafts have been used with satisfactory outcome 
being reported.9 However, this option may be contraindi-
cated in patients with associated Kaposi’s sarcoma. 
The occurrence together of Kaposi’s sarcoma (with or 
without associated lymphoedema) and vascular manifesta-
tions of HIV may be considered an uncommon presentation 
in the HIV patient; however, the sheer scale of the pandemic 
will see an increase of this problem that will prompt innova-
tive clinical decisions to facilitate appropriate therapy. 
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